» Articles » PMID: 29755162

Bayesian Regression Model for Recurrent Event Data with Event-varying Covariate Effects and Event Effect

Overview
Journal J Appl Stat
Specialty Public Health
Date 2018 May 15
PMID 29755162
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

In the course of hypertension, cardiovascular disease events (e.g., stroke, heart failure) occur frequently and recurrently. The scientific interest in such study may lie in the estimation of treatment effect while accounting for the correlation among event times. The correlation among recurrent event times come from two sources: subject-specific heterogeneity (e.g., varied lifestyles, genetic variations, and other unmeasurable effects) and event dependence (i.e., event incidences may change the risk of future recurrent events). Moreover, event incidences may change the disease progression so that there may exist event-varying covariate effects (the covariate effects may change after each event) and event effect (the effect of prior events on the future events). In this article, we propose a Bayesian regression model that not only accommodates correlation among recurrent events from both sources, but also explicitly characterizes the event-varying covariate effects and event effect. This model is especially useful in quantifying how the incidences of events change the effects of covariates and risk of future events. We compare the proposed model with several commonly used recurrent event models and apply our model to the motivating lipid-lowering trial (LLT) component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (ALLHAT-LLT).

Citing Articles

Bayesian criterion-based assessments of recurrent event models with applications to commercial truck driver behavior studies.

Zhang Y, Chen M, Guo F Stat Med. 2022; 41(23):4607-4628.

PMID: 35871759 PMC: 9796651. DOI: 10.1002/sim.9528.

References
1.
Aalen O, Husebye E . Statistical analysis of repeated events forming renewal processes. Stat Med. 1991; 10(8):1227-40. DOI: 10.1002/sim.4780100806. View

2.
Huang X, Liu L . A joint frailty model for survival and gap times between recurrent events. Biometrics. 2007; 63(2):389-97. DOI: 10.1111/j.1541-0420.2006.00719.x. View

3.
Hougaard P . Frailty models for survival data. Lifetime Data Anal. 1995; 1(3):255-73. DOI: 10.1007/BF00985760. View

4.
Davis B, Cutler J, Gordon D, Furberg C, Wright Jr J, Cushman W . Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens. 1996; 9(4 Pt 1):342-60. DOI: 10.1016/0895-7061(96)00037-4. View

5.
Gonzalez J, Pena E, Slate E . Modelling intervention effects after cancer relapses. Stat Med. 2005; 24(24):3959-75. PMC: 4066387. DOI: 10.1002/sim.2394. View